Efficacy and safety comparison study of 0.1 p. 100 and 0.03 p. 100 adapalene gels and tretinoin gel in the topical treatment of acne;ETUDE COMPARATIVE DE L'EFFICACITE ET DE LA TOLERANCE DE GELS D'ADAPALENE A 0,1 ET 0,03 P. 100 ET D'UN GEL DE TRETINOINE A 0,025 P. 100 DANS LE TRAITEMENT DE L'ACNE

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 3, 1996, Pages 165-170

  Alirezai, M ^a   Meynadier, J ^a   Jablonska, S ^b   Czernielewski, J ^c   Verschoore, M ^c  

^a Hopital Saint Charles   (France)

^b Klinika Dermatologiczna Medical University of Warsaw   (Poland)

^c Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DIFFERINE; RETINOIC ACID; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GELS; HUMANS; KERATOLYTIC AGENTS; MALE; NAPHTHALENES; TIME FACTORS; TRETINOIN;

EID: 0029986751     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kligman AM, Fulton JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969;99:471-6.
2. Reichert U, Bernardon JM, Charpentier B et al. Synthetic retinoids: Receptor selectivity and biological activity. In: Bernard BA, Shroot B (eds): From Molecular Biology to Therapeutics. Pharmacol Skin. Basel, Karger, 1983;5:117-27.
3. Bernard BA. Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol 1993;6(suppl. 1):61-9.
4. Chatelus A, Caron JC, Shroot B, Eustache J, Hensby CN. Structure-activity relationships between different retinoids using the topical rhino mouse comedolytic model. In: Reichert U, Shroot B (eds). Pharmacology of Retinoids in the Skin. Pharmacol Skin. Basel, Karger, 1989;3:144-8.
5. Bouclier M, Chatelus A, Ferracin J, Delain C, Shrot B, Hensby CN. Quantification of epidermal histological changes induced by topical retinoids and CD 271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol 1991;4:65-73.
6. Hensby CN, Cavey D, Bouclier M et al. The in vivo and in vitro anti-inflammatory activity of CD 271, a new retinoic-like modulator of cell differentiation. In: Reichert U, Shroot B (eds). Pharmacology of Retinoids in the Skin. Pharmacol Skin. Basel, Karger, 1989;3:160-2.
7. Burke BM, Cunliffe WJ. The assessment of acne vulgaris. The Leeds technique. Br J Dermatol 1984;3:83-92.
8. Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J. Vehicle controlled study of CD 271 lotion in the topical treatment of acne vulgaris. J Invest Dermatol 1993;100:221.
9. Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J, Schaefer H. Efficacy and safety of topical 0.03 and 0.1 p. 100 CD 271 alcoholic gel. A new treatment candidate in acne vulgaris. Dermatologica 1990;181:351-2.
10. Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J, Schaefer H. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:368-71.
11. Leu F, Schmid U, Fournet M, Truffat C. Etude randomisée de l'effet de deux concentrations d'acide rétinoique dans l'acné vulgaire. Med Hyg 1974;32:1684-7.
12. ®) in acne vulgaris. A controlled clinical trial. Dermatologica 1974;148:82-9.
13. Mandy SA, Thorne EG. A comparison of the efficacy and safety of tretinoin cream 0.025 and 0.05 p. 100. Adv Ther 1990;7:94-9.
14. Krishnan G. Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris. Practitioner 1976;216:106-9.
15. Gandola M, Argenziano G, Barba C et al. Topical vitamin A acid in the treatment of acne vulgaris (a controlled multicenter trial). Arch Dermatol Res 1976;255:129-38.
16. Elbaum DJ. Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol 1988;19:486-91.